INNO Diagnostics and Research Centers for Minority Institutions (RCMI) scientists from the Ponce Research Institute, Center for Scientific Research at Ponce Health Sciences University (PHSU), detect a SAR-CoV-2 virus that realizes the cause of COVID-19 and pruebas and the island.
The cepa identified by the PHSU scientists contains the 69-70 partition, which is presented in the variant that was recently detected in the United Kingdom, UK B.1.1.7. As of recently published data by the Centers for Disease Control and Prevention (CDC), the United States has identified 315 cases of this variant, as indicated by the Dra. Vanessa Rivera-Amill, Scientific Director of INNO Diagnostics.
From December 2020, we will begin analyzing the results of diagnostic tests to determine whether we have interest patterns. In the laboratory we develop an assay that we are allowed to confirm if we do not have the variant between the exempt samples. From these, the group of scientists composed by the laboratory technicians Andrea Arias and Raphael Sánchez, the clinical director Dr. Gerardo Hernández, along with this server, we will begin the process of investigating the detection of the SARS-CoV-2 virus variant, “Rivera-Amill indicated, explaining that this variant was detected earlier in Iceland has public implications, then the revised literature establishes that these variants can be promoted with mayor facility between the persons. However, if the identification of this variant is an important step for the scientific community of the country, it could “help mitigate the impact of propagation in the communities”.
For his part, Dr. Kenira Thompson, president of the Ponce Research Institute and vice president of PHSU research, announced that, while confirming the identification of the variant, he communicated immediately with the Secretary of Health of Puerto Rico. “We believe that it is probable that in Puerto Rico there are variants of COVID-19. As scientists, our responsibility is to prove dates that help, not only for the development of other scientific tests, we will, in addition, in the prevention strategies that live in the country. We have a team of scientists with a high sense of compromise and dedication to the scientists who are in Puerto Rico. “Since the beginning of the maneuver of the pandemic in the island, we are working without descent to bring, from the scientific camp, in identifying solutions that allow us to protect health and the life of all,” Thompson said.
INNO Diagnostics is an Immunology Reference Laboratory and the first laboratory affiliated with an academic center to process molecular samples to detect the virus that causes COVID-19. With 30 years of establishment, INNO Diagnostics has been characterized by the development and implantation of reference diagnostic tests, as well as genotyping, and the viral load detection for VIH. It is the only laboratory certified by the National Organization of Health (WHO, by its flags in English) for the genotyping of VIHs in Puerto Rico, the Caribbean and Latin America and provides diagnostic services to these regions.
To know more about Ponce Health Sciences University, interested people can visit www.psm.edu
Recommended news: